NCT03928457

Brief Summary

The massive use of highly technological devices in Neonatal Intensive Care Units may expose preterm neonates to electromagnetic fields, especially radiofrequencies, at low doses but continuously and chronically. Strikingly, the effect of long-term exposure to radiofrequencies on the neurophysiological development of preterm neonates has never been studied so far. The only studies on the impact of chronic exposure to radiofrequencies have been conducted in animals or adult humans, whereas preterm infants may be particularly vulnerable due to increased penetration of radiofrequency waves into the brain during a crucial period of neurodevelopment. The present project will aim at 1) quantifying individual levels of chronic exposure (during 6 weeks) to which preterm neonates are subjected during their stay in the Neonatal Intensive Care Unit, 2) following the evolution of the thermal environment and of the clinical parameters of the neonates after birth, 3) identifying potential alterations of neurophysiological activity (sleep, cerebral hemodynamics, autonomic nervous activity) which will be correlated to actual levels of chronic RF-EMF (radiofrequency electromagnetic fields) exposure.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2019

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

April 16, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 26, 2019

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2023

Completed
Last Updated

May 10, 2023

Status Verified

May 1, 2023

Enrollment Period

4.1 years

First QC Date

April 16, 2019

Last Update Submit

May 9, 2023

Conditions

Keywords

preterm neonateradiofrequency exposureneurophysiological functions

Outcome Measures

Primary Outcomes (4)

  • total sleep time in hours

    Sleep Structure will be determined by measuring total sleep time, absolute and relative durations of sleep states and sleep state change frequency.

    from birth to 6 weeks of life

  • absolute durations of sleep states in hours

    Sleep Structure will be determined by measuring total sleep time, absolute and relative durations of sleep states and sleep state change frequency.

    from birth to 6 weeks of life

  • relative durations of sleep states in hours

    Sleep Structure will be determined by measuring total sleep time, absolute and relative durations of sleep states and sleep state change frequency.

    from birth to 6 weeks of life

  • sleep state change frequency

    Sleep Structure will be determined by measuring total sleep time, absolute and relative durations of sleep states and sleep state change frequency.

    from birth to 6 weeks of life

Secondary Outcomes (6)

  • Cerebral hemodynamics

    from birth to 6 weeks of life

  • Autonomic nervous system activity

    from birth to 6 weeks of life

  • apnea frequency

    from birth to 6 weeks of life

  • bradycardia frequency

    from birth to 6 weeks of life

  • desaturation frequency

    from birth to 6 weeks of life

  • +1 more secondary outcomes

Study Arms (1)

preterm neonate

EXPERIMENTAL
Other: Parental questionnaireOther: Daily continuous recording of radiofrequency exposure levelsOther: Follow-up of daily infants environmental and clinical parametersOther: Nocturnal polysomnographyDiagnostic Test: cerebral hemodynamicsDiagnostic Test: activity of the autonomic nervous system

Interventions

Parental questionnaire on pregnancy history and environmental exposure

preterm neonate

Daily continuous recording of radiofrequency exposure levels (6 weeks) by placing a dosimeter inside the incubator

preterm neonate

Follow-up of daily infants environmental and clinical parameters: morphological characteristics, drugs, ventilatory support, dietary management, clinical outcomes, incubator data (temperatures…)

preterm neonate

Nocturnal polysomnography (at 3 and 6 weeks of life, between 8 pm and 8 am) with recording of sleep (electroencephalography, electrooculography),

preterm neonate
cerebral hemodynamicsDIAGNOSTIC_TEST

cerebral hemodynamics (near infrared spectroscopy)

preterm neonate

activity of the autonomic nervous system (electrocardiography, analysis of heart rate variability)

preterm neonate

Eligibility Criteria

AgeUp to 1 Day
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • preterm neonates born at 26 to 34 weeks of gestational age
  • signed written informed consent form

You may not qualify if:

  • infants infected
  • infants suffering from neurological disorders
  • serious heart, respiratory, digestive or metabolic diseases
  • infants born from mothers aged less than 18 years old or deprived of their parental rights
  • non covered by national health insurance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Amiens

Amiens, 80054, France

Location

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Pierre Tourneux, Pr

    CHU Amiens

    PRINCIPAL INVESTIGATOR
  • François Moreau, MD

    CHU Amiens

    PRINCIPAL INVESTIGATOR
  • Lucie Aimée Razafimanantsoa, MD

    CHU Amiens

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 16, 2019

First Posted

April 26, 2019

Study Start

April 1, 2019

Primary Completion

May 1, 2023

Study Completion

August 1, 2023

Last Updated

May 10, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations